by Caroline Fife, M.D. | Apr 16, 2025 | Cellular / Tissue-Based Products, CTP / Skin Substitutes
SmartTRAK is reporting that in the 4th quarter of 2024 (Q424) the “skin substitute” market reached almost $2 billion, an increase of 25% compared to the 4th quarter of 2023 (Q423). Human amniotic products represent the majority of the US market at 76.3%, up from 72.1%...
by Caroline Fife, M.D. | Apr 14, 2025 | Cellular / Tissue-Based Products, CTP / Skin Substitutes
I didn’t write the New York Times article about “skin substitutes” It was written by Sarah Kliff and Katie Thomas. You can send them your comments at nytimes.com/tips. Jeanne Pinder at Clear Health Costs also has a new article: “Wound Care Regulations Delayed...
by Caroline Fife, M.D. | Apr 11, 2025 | Cellular / Tissue-Based Products, CTP / Skin Substitutes
Check out the article in the New York Times about “skin substitutes.” Medicare Bleeds Billions on Pricey Bandages, and Doctors Get a Cut – The New York Times “Medicare spending on ‘skin substitutes’ made of dried placenta has soared as doctors pocket...
by Caroline Fife, M.D. | Apr 11, 2025 | Cellular / Tissue-Based Products, CTP / Skin Substitutes
LCDs appear to be delayed until 1/1/26 based on MAC websites changing the revision effective date. More news as I get it. There’s now an amniotic that is over $5,000 per cm2. I wonder how high the prices will go by next January? CMS Statement on Local Coverage...
by Caroline Fife, M.D. | Apr 9, 2025 | Cellular / Tissue-Based Products, CTP / Skin Substitutes
An opinion piece has been published in RealClear Health about the upcoming launch of the “skin substitute” LCD(s), authored by the president of Consumer Action for a Strong Economy (CASE). (RealClear Health is part of RealClear Politics). The article...
by Caroline Fife, M.D. | Apr 8, 2025 | Cellular / Tissue-Based Products, CTP / Skin Substitutes
Here’s another guest blog from Michael Crouch who is a professional coder and medical auditor, detailing the documentation demands of the LCDs. It’s true that we don’t know if the LCDs will be implemented on April 13th. However, with or without the implementation...
by Caroline Fife, M.D. | Mar 28, 2025 | Cellular / Tissue-Based Products, CTP / Skin Substitutes
Welcome to the Circus: The State of Healthcare in America | medicaidlaw-nc Attorney Knicole Emanuel has another blog post (yes, I am a big fan of her blog) about Medicare audits. She describes “compliance” as a “Kafkaesque masterpiece of government regulation.” The...
by Caroline Fife, M.D. | Mar 18, 2025 | Cellular / Tissue-Based Products, CTP / Skin Substitutes, Medicare Audits
Here’s a guest blog from Martha Kelso, Chief Regulatory Officer at Wound Care Plus, LLC, providing a heads-up about the documentation demands for her most recent audit of CTPs/CAMPs/skin substitutes – this time a UPIC audit. According to the Medicare Program Integrity...
by Caroline Fife, M.D. | Mar 17, 2025 | Cellular / Tissue-Based Products, CTP / Skin Substitutes
Check out Jeanne Pinder’s newest Clear Health Costs article about the “skin substitute” market. She interviewed practices that have raised serious concerns about skyrocketing wound care spending, including claims of $1 million per patient, with questionable benefit....
by Caroline Fife, M.D. | Mar 7, 2025 | Cellular / Tissue-Based Products, CTP / Skin Substitutes
Many of you are aware of a post on President Trump’s social media platform implying that the administration would bring an end to the skin substitute LCD(s) and suggesting that their implementation will lead to more DFU amputations. You can see the post on Jeanne...
